GPCR | Structure Therapeutics Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	36.30 - 38.44
52 Week Range	26.61 - 75.02
Beta	-3.11
Implied Volatility	82.80%
IV Rank	22.93%
Day's Volume	464,791
Average Volume	871,943
Shares Outstanding	60,077,285
Market Cap	2,219,855,681
Sector	Healthcare
Industry	Biotechnology
IPO Date	2023-02-03

Valuation
Profitability
Growth
Health
P/E Ratio	-16.87
Forward P/E Ratio	N/A
EPS	-2.19
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	111
Country	USA
Website	GPCR

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.

GPCR's peers: ALDX, ANNX, ASLN, AVTX, CERE, CRNX, CMPX, GHRS, HRMY, HUMA, IOBT, KNSA, LGND, MDXG, NUVL, OMGA, PHAT, QURE, RCUS, SVRA, TVTX, VCYT, VNDA, VRDN, VTYX, MLTX, ERNA, IRON, MLEC, ELVN, DAWN, XFOR, INZY, ABOS, MREO, TERN, AMLX, ELDN, HOOK, BMEA, DICE, MORF, CVKD

*Chart delayed

Analyzing fundamentals for GPCR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see GPCR Fundamentals page.

Watching at GPCR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on GPCR Technicals page.